Table 1.
Patient demographics
| Characteristic | Placebo (n = 10)a | Darbepoetin alfa (n = 16)a |
|---|---|---|
| Sex (male) | 4 | 10 |
| GA (weeks) | 38.1 ± 1.7 | 38.4 ± 1.2 |
| PNA (h) | 9.0 ± 1.4 | 9.7 ± 2.2 |
| PMA (weeks) | 38.1 ± 1.7 | 38.4 ± 1.1 |
| BWT (kg) | 3.09 ± 0.39 | 3.03 ± 0.43 |
| Sarnat scoreb | ||
| 2 | 8 | 10 |
| 3 | 2 | 6 |
BWT birthweight, GA gestational age, HIE hypoxic ischemic encephalopathy, PMA postmenstrual age, PNA postnatal age
a
n or mean ± standard deviation
b
The Sarnat Grading Scale of Hypoxic Ischemic Encephalopathy is a scoring system used to grade the severity of an HIE injury. Scores of 2 and 3 represent moderate and severe HIE injuries, respectively